Synthesis and anti-inflammatory activity evaluation of novel chroman derivatives-Reference-Cited by-同舟云学术

Synthesis and anti-inflammatory activity evaluation of novel chroman derivatives

Published:2020 Issue:32 Volume:44 Page:13716-13727
ISSN:1144-0546
Container-title:New Journal of Chemistry
language:en
Short-container-title:New J. Chem.

Author:

Matta Akanksha¹²³⁴⁵,Sharma Ajendra K.¹²³⁴⁵,Tomar Shilpi¹²³⁴⁵,Cao Pei¹²³⁴⁵,Kumar Sandeep¹²³⁴⁵,Balwani Sakshi⁶⁷⁸⁹⁴,Ghosh Balaram⁶⁷⁸⁹⁴,Prasad Ashok K.¹²³⁴⁵^ORCID,Van der Eycken Erik V.¹⁰²¹¹¹²¹³^ORCID,DePass Anthony L.¹⁴¹⁵¹⁶¹⁷¹⁸,Wengel Jesper¹⁹²⁰²¹²²²³^ORCID,Parmar Virinder S.¹²³⁴⁵,Len Christophe²⁴²⁵²⁶²⁷²⁸^ORCID,Singh Brajendra K.¹²³⁴⁵

Affiliation:

1. Bioorganic Laboratory

2. Department of Chemistry

3. University of Delhi

4. Delhi 110 007

5. India

6. Molecular Immunogenetics Lab

7. Genomics and Molecular Medicine Unit

8. Institute of Genomics and Integrative Biology (CSIR-IGIB)

9. Mall Road

10. Laboratory for Organic & Microwave-Assisted Chemistry (LOMAC)

11. University of Leuven

12. B-3001 Leuven

13. Belgium

14. Department of Biology

15. Long Island University

16. One University Plaza

17. Brooklyn

18. USA

19. Department of Physics

20. Chemistry and Pharmacy

21. University of Southern Denmark

22. DK 5230 Odense M

23. Denmark

24. Chimie ParisTech

25. PSL University

26. CNRS

27. Institute of Chemistry for Life and Health Sciences – i-CLeHS

28. F-75005 Paris

Abstract

In an effort to develop potent anti-inflammatory agents, a series of novel chroman derivatives including acyclic amidochromans, chromanyl esters and chromanyl acrylates have been designed, synthesized and fully characterized.

Funder

University of Delhi

Department of Science and Technology, Ministry of Science and Technology

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,General Chemistry,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2020/NJ/D0NJ02125C

Reference27 articles.

1. Drugs, inflammation and cell adhesion receptors

2. Moving targets: cell migration inhibitors as new anti-inflammatory therapies